Scarica l'app Stockscreener
5.67
14.78%
0.73
Precedente Chiudi:
$4.94
Aprire:
$5.55
Volume 24 ore:
13.67M
Relative Volume:
7.66
Capitalizzazione di mercato:
$565.43M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-15.57
EPS:
-0.3641
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
+12.28%
1M Prestazione:
+47.27%
6M Prestazione:
+90.27%
1 anno Prestazione:
+9.04%
Intervallo 1D:
$5.471
$6.00
Intervallo di 1 settimana:
$4.78
$6.00
Portata 52W:
$2.12
$6.00
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Nome
Aquestive Therapeutics Inc
Settore
Telefono
908-941-1900
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Confronta AQST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
5.67 | 597.61M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
145.88 | 65.19B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.06 | 47.44B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.16 | 41.29B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.35 | 21.16B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
417.57 | 18.54B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-04-22 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-03 | Iniziato | Lake Street | Buy |
| 2018-08-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-08-20 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Aquestive Therapeutics (NASDAQ:AQST) Reaches New 12-Month HighStill a Buy? - MarketBeat
Stock Traders Purchase Large Volume of Call Options on Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat
After Leaping 28% Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Are Not Flying Under The Radar - 富途牛牛
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday - Benzinga
Aug Technicals: What is the earnings history of Aquestive Therapeutics IncJuly 2025 Macro Moves & Verified Trade Idea Suggestions - khodrobank.com
Aquestive Therapeutics’ SWOT analysis: needle-free epinephrine stock poised for growth - Investing.com Canada
Macro Review: What is Aquestive Therapeutics Inc. s P E ratio telling usQuarterly Profit Report & Daily Technical Forecast Reports - khodrobank.com
Aquestive Therapeutics rises after pricing $85M stock offering - MSN
Aquestive Therapeutics (NASDAQ:AQST) Trading Up 5.2%Here's Why - MarketBeat
Aquestive Therapeutics Inc. stock trend forecastWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com
Whats the fair value of Aquestive Therapeutics Inc stockJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - khodrobank.com
Profit Recap: Whats the RSI of Aquestive Therapeutics Inc stock2025 Market Sentiment & Target Return Focused Stock Picks - khodrobank.com
Value Recap: What are Aquestive Therapeutics Inc.’s recent SEC filings showing - khodrobank.com
Performance Recap: Is Adtalem Global Education Inc being accumulated by smart moneyRate Cut & AI Enhanced Trading Alerts - خودرو بانک
Analyst Downgrade: What is the earnings history of Aquestive Therapeutics Inc2025 Sector Review & Fast Entry High Yield Tips - خودرو بانک
Buyout Rumor: Is Aquestive Therapeutics Inc forming a bullish divergenceRecession Risk & Short-Term High Return Strategies - khodrobank.com
Aug Mood: Can Aquestive Therapeutics Inc. grow without external fundingJuly 2025 Action & AI Forecast for Swing Trade Picks - خودرو بانک
Aug Summary: Is Aquestive Therapeutics Inc. stock good for income investorsEntry Point & Consistent Profit Trading Strategies - khodrobank.com
Oppenheimer Issues Positive Forecast for Aquestive Therapeutics (NASDAQ:AQST) Stock Price - MarketBeat
Peter E. Boyd Sells 15,000 Shares of Aquestive Therapeutics (NASDAQ:AQST) Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Trading Down 6.4% Following Insider Selling - MarketBeat
Aquestive, Veeva, Oklo, BioMarin, TKO: Trending by Analysts - TipRanks
Aquestive Therapeutics Highlights at Global Investor Conference - MSN
Aquestive Therapeutics, Inc. $AQST Shares Bought by Everstar Asset Management LLC - MarketBeat
Aquestive Bets Big On Oral Epinephrine’s Market Debut - Finimize
Analysts Offer Predictions for AQST Q3 Earnings - MarketBeat
Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $8 - 富途牛牛
Aquestive Therapeutics (NASDAQ:AQST) Stock Rating Upgraded by Lifesci Capital - MarketBeat
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - MSN
Aquestive Therapeutics SVP sells $79,500 in shares By Investing.com - Investing.com South Africa
Aquestive therapeutics (AQST) COO Jung Cassie sells $310,900 in shares By Investing.com - Investing.com Australia
Aquestive Therapeutics SVP sells $79,500 in shares - Investing.com
Aquestive therapeutics (AQST) COO Jung Cassie sells $310,900 in shares - Investing.com
Aquestive Therapeutics at H.C. Wainwright: Anaphylm™ Poised for Growth - Investing.com
Aquestive Therapeutics at H.C. Wainwright: Anaphylm™ Poised for Growth By Investing.com - Investing.com Canada
Multi Factor Analysis Ranks Aquestive Therapeutics Inc. as Strong BuyMarket Activity Report & Community Consensus Picks - beatles.ru
Aquestive Therapeutics: De-risking and Strategic Positioning for Success in the Type 1 Allergy Market - TipRanks
Aquestive Therapeutics says FDA AdCom not needed for review of Anaphylm - The Pharma Letter
Measuring Aquestive Therapeutics Inc.’s beta against major indicesEarnings Summary Report & Capital Efficient Trading Techniques - Newser
Aquestive Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Aquestive Therapeutics: Expect Its Torrid Pace To Relax (Rating Downgrade) (NASDAQ:AQST) - Seeking Alpha
Pullback Watch: What are Aquestive Therapeutics Inc.’s recent SEC filings showing2025 Retail Activity & Capital Efficiency Focused Ideas - خودرو بانک
Is Aquestive Therapeutics Inc. stock a smart retirement pickWeekly Investment Summary & Capital Protection Trading Alerts - خودرو بانک
What are Aquestive Therapeutics Inc.’s recent SEC filings showingJuly 2025 Trends & Verified Swing Trading Watchlists - خودرو بانک
Aquestive jumps as FDA says no AdCom for allergy therapy Anaphylm - MSN
Aquestive Therapeutics' Strategic Path to Anaphylm Approval and Market Capture - AInvest
Aquestive Therapeutics: No AdCom For Anaphylm Derisks January Approval Catalyst (AQST) - Seeking Alpha
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aquestive Therapeutics Inc Azioni (AQST) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jung Cassie | Chief Operating Officer |
Sep 04 '25 |
Option Exercise |
1.93 |
50,000 |
96,408 |
345,526 |
| Jung Cassie | Chief Operating Officer |
Sep 04 '25 |
Sale |
5.00 |
62,180 |
310,900 |
283,346 |
| Boyd Peter E. | See Remarks |
Sep 05 '25 |
Sale |
5.30 |
15,000 |
79,500 |
288,323 |
2.66%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):